Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.1K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.1K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.8K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.8K
Neural Regulation01:37

Neural Regulation

43.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.5K
Brain Imaging01:14

Brain Imaging

763
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans),  magnetic resonance imaging (MRI),  functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
763

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Left and Right Hemispheric Contribution to Social Cognition].

Brain and nerve = Shinkei kenkyu no shinpo·2018
Same author

Decision-making performance in Parkinson's disease correlates with lateral orbitofrontal volume.

Journal of the neurological sciences·2016
Same author

[Decision Making and Electrodermal Activity].

Brain and nerve = Shinkei kenkyu no shinpo·2016
Same author

[Social Cognitive Impairment in Myotonic Dystrophy Type 1].

Brain and nerve = Shinkei kenkyu no shinpo·2016
Same author

[Disorders of body schema].

Brain and nerve = Shinkei kenkyu no shinpo·2014
Same author

[Neurological disease and facial recognition].

Brain and nerve = Shinkei kenkyu no shinpo·2012

Related Experiment Video

Updated: Feb 18, 2026

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

16.3K

[Voxel-Based Morphometry and Social Cognitive Function in Parkinson's Disease].

Mutsutaka Kobayakawa1

  • 1Department of Informatics, Faculty of Informatics, Tokyo University of Information Sciences.

Brain and Nerve = Shinkei Kenkyu No Shinpo
|November 25, 2017
PubMed
Summary

Voxel-based morphometry (VBM) reveals brain volume changes in Parkinson's disease (PD) patients, affecting limbic and neocortical areas. These structural changes correlate with cognitive and social function deficits in PD.

More Related Videos

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

16.4K
Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

8.4K

Related Experiment Videos

Last Updated: Feb 18, 2026

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

16.3K
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

16.4K
Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

8.4K

Area of Science:

  • Neuroimaging
  • Neurology
  • Cognitive Neuroscience

Background:

  • Voxel-based morphometry (VBM) is a key neuroimaging technique for studying brain structure in Parkinson's disease (PD).
  • PD patients exhibit distinct patterns of brain volume reduction, differing between early and advanced disease stages.
  • Local brain volume alterations are increasingly linked to cognitive and social functioning impairments in PD.

Purpose of the Study:

  • To review and synthesize findings from VBM studies on brain structural changes in Parkinson's disease.
  • To explore the relationship between brain volume alterations and social-cognitive deficits in PD.
  • To identify discrepancies in current VBM research and suggest future directions.

Main Methods:

  • Systematic review of VBM studies investigating brain structure in Parkinson's disease.
  • Analysis of findings related to limbic, paralimbic, and neocortical regions.
  • Examination of correlations between brain volume and social-cognitive functions (e.g., facial emotion recognition, theory of mind).

Main Results:

  • Early PD stages show reduced volume in limbic/paralimbic areas; advanced stages affect neocortical regions (temporal, frontal).
  • Significant correlations exist between local brain volume and cognitive performance in PD patients.
  • VBM studies have increasingly focused on social-cognitive functions, revealing insights into communication and behavioral disorders.

Conclusions:

  • VBM is crucial for understanding structural brain changes in PD and their impact on cognition.
  • Discrepancies in VBM results highlight the need for methodological standardization and larger sample sizes.
  • Future research should integrate VBM with brain perfusion and network connectivity analyses for a comprehensive understanding of PD's neurological underpinnings.